Kenichi Hashimoto
Overview
Explore the profile of Kenichi Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Requena G, Camidge L, Ford A, Yarita M, Hashimoto K, Jennison T, et al.
Int J Chron Obstruct Pulmon Dis
. 2025 Mar;
20:565-580.
PMID: 40078928
Purpose: Following the relatively recent introduction of single-inhaler triple therapies in Japan, this study compared the effectiveness of switching from multiple-inhaler triple therapy (MITT) to once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) by...
2.
Saito A, Sato S, Kobayashi T, Sun G, Hashimoto K, Hakozaki Y, et al.
Crit Care
. 2025 Jan;
29(1):5.
PMID: 39754252
No abstract available.
3.
Joksaite S, Wood R, Ismaila A, Camidge L, Mizukami A, Czira A, et al.
BMJ Open
. 2024 Dec;
14(12):e080864.
PMID: 39632104
Objectives: To evaluate and compare medication adherence and persistence for patients newly initiating single-inhaler triple therapy (SITT) and multiple-inhaler triple therapy (MITT) for chronic obstructive pulmonary disease (COPD) in Japan....
4.
Kobayashi T, Matsui T, Sugita I, Tateda N, Sato S, Hashimoto K, et al.
Sensors (Basel)
. 2024 Nov;
24(22).
PMID: 39598879
In 2020, 20% of patients with COVID-19 developed severe complications, including life-threatening pneumonia with systemic inflammatory response syndrome (SIRS). We developed a preliminary SIRS monitor that does not require blood...
5.
Horiuchi Y, Hashimoto K, Yoshida R, Sekizawa A, Kubota A, Maeda M, et al.
Clin Case Rep
. 2024 Jun;
12(6):e8990.
PMID: 38831985
Key Clinical Message: In a patient with anti-aminoacyl tRNA synthetase antibody and anti-OJ antibody syndrome, interventions likes warming, prostaglandins, and antiplatelets failed. However, prednisolone pulse treatment rapidly halted disease progression....
6.
Kimata M, Hashimoto K, Harada N, Kawamura Y, Kimizuka Y, Fujikura Y, et al.
Medicina (Kaunas)
. 2024 Apr;
60(4).
PMID: 38674301
Coronavirus disease 2019 (COVID-19) has affected medical practice. More than 7,000,000 patients died worldwide after being infected with COVID-19; however, no specific laboratory markers have yet been established to predict...
7.
Asaga T, Hashimoto K, Kawamura Y, Fujita N, Kimata M, Sekizawa A, et al.
Medicine (Baltimore)
. 2024 Feb;
103(7):e36782.
PMID: 38363934
Rationale: Although patients with central disorders of hypersomnolence (CDH) exhibit characteristic symptoms of hypersomnia frequently, it takes 5 to 15 years from the onset for its diagnosis due to the...
8.
Sekizawa A, Nagano A, Hashimoto K, Ono Y
Cleve Clin J Med
. 2024 Jan;
91(1):20-21.
PMID: 38167396
No abstract available.
9.
Fujita N, Ono Y, Hashimoto K, Kawamura Y, Kimata M, Sekizawa A, et al.
Osteoporos Int
. 2023 Dec;
35(4):733-736.
PMID: 38102330
A 70-year-old female patient was admitted for close examination and treatment of hypercalcemia (corrected serum calcium levels: 3.04 mmol/L) and renal dysfunction (serum creatinine levels: 254.59 µmol/L). The patient had...
10.
Czira A, Akiyama S, Ishii T, Wood R, Camidge L, Wallis H, et al.
Int J Chron Obstruct Pulmon Dis
. 2023 Dec;
18:2933-2953.
PMID: 38089540
Purpose: There is currently limited evidence for the optimal timing of triple therapy initiation in Japan, which is crucial for optimizing strategies for the effective treatment of chronic obstructive pulmonary...